RenovoRx

Public

—N/Ahttps://www.renovorx.com

Last Round

Private Placement

Apr 9, 2026

Total Funding Raised

$10M

Company Overview

RenovoRx, Inc. is a clinical-stage biopharmaceutical company that develops precision oncology therapies. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed for the targeted delivery of therapeutic agents to solid tumors, aiming to increase efficacy while minimizing systemic toxicities. Its lead product candidate, RenovoGem, is a drug-device combination product being evaluated in a Phase III clinical trial for the treatment of locally advanced pancreatic cancer. The company is also commercializing its FDA-cleared RenovoCath delivery device as a standalone product, with first commercial orders received in late 2024. RenovoRx is a public company listed on the Nasdaq under the ticker RNXT.

AI Layer

Non-AI

Keywords

Trans-Arterial Micro-Perfusion (TAMP) therapy platformFDA-cleared drug delivery catheter (RenovoCath)treatment for locally advanced pancreatic cancer (LAPC)local chemotherapy delivery systeminvestigational drug-device combination (RenovoGem)targeted oncology therapy for solid tumorsarterial micro-perfusion systemoncology medical device for interventional radiologypancreatic cancer therapybile duct cancer therapy

RenovoRx Comps

Public and private peers based on sector, stage, and business model.

RenovoRx comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RenovoRx Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Apr 9, 2026

View all Funding Rounds

RenovoRx Investors

Notable investors and investment history

RenovoRx investors
Investor	Rounds
Pathfinder Asset Management Limited	Private Placement
Transcend Partners	Private Placement
Bleichroeder	Private Placement

View all Investors

RenovoRx Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RenovoRx Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range26

Year Founded2009

Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.